Tominersen (sodium)
Tominersen sodium is a second-generation 2′-O- (2-methoxyethyl) antisense oligonucleotide that targets huntingtin protein (HTT) mRNA and potently suppresses HTT production. Tominersen improves survival and reduces brain atrophy in mice. Tominersen sodium can be used for the research of Huntington’s disease (HD) [1][2].
Product Specifications
Product Name Alternative
RG6042 (sodium) ; IONIS-HTTRx (sodium)
UNSPSC
12352208
Target
Huntingtin
Type
Oligonucleotides
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tominersen-sodium.html
Purity
97.36
Solubility
10 mM in H2O
Smiles
[Tominersen(sodium)]
Molecular Formula
C230H299N74Na20O122P19S13
Molecular Weight
7078 (free acid)
References & Citations
[1]Kordasiewicz HB, et al. Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron. 2012 Jun 21;74 (6) :1031-44.|[2]Tabrizi SJ, et, al. Targeting Huntingtin Expression in Patients with Huntington's Disease. N Engl J Med. 2019 Jun 13;380 (24) :2307-2316.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941528-100 1x 100 µL
BTLA (BTLA/1528), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
